BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Doxorubicin
,
rs3825942
,
SLC12A1
,
G-protein-coupled receptor binding
,
Obesity
,
Neuron
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
pum2 protein human
Summary
General Info
Curated Studies
Most Correlated Studies
Cervical cancer HeLa cells with shRNA knockdown of RNA-binding protein Pumilio2 (PUM2)
Osteosarcoma U-2 OS cells after PUM1, PUM2 or NORAD overexpression and siRNA knockdown
Embryonic kidney 293 cells with PUM1 and PUM2 siRNA knockdown
Colorectal cancer HCT cells with NORAD knockout or overexpressing PUM1 or PUM2
HEK293 cells after siRNA knockdown of IGF2BP1-3 and inducible expression of FLAG-HA-IGF2BP1
Explore Curated Studies Results
Literature
Most Relevant Literature
Chemi-Northern: a versatile chemiluminescent northern blot method for analysis and quantitation of R…
PIE-seq: identifying RNA-binding protein targets by dual RNA-deaminase editing and sequencing.
A comprehensive thermodynamic model for RNA binding by the Saccharomyces cerevisiae Pumilio protein …
NORAD accelerates skin wound healing through extracellular vesicle transfer from hypoxic adipose der…
PUMILIO-mediated translational control of somatic cell cycle program promotes folliculogenesis and c…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for pum2 protein human
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ